CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +4,564 | 18,904 | ||
| 2022-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Shares withheld for taxes | −2,012 | $3.01 | $6K | 16,892 |
| 2022-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 11,250 | ||
| 2022-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −4,564 | 41,628 | ||
| 2022-07-13 | Quart Barry D Chief Executive Officer | Option exercise | +3,646 | 136,334 | ||
| 2022-07-13 | Quart Barry D Chief Executive Officer | Option exercise | +16,122 | 152,456 | ||
| 2022-07-13 | Quart Barry D Chief Executive Officer | Shares withheld for taxes | −5,219 | $3.01 | $16K | 147,237 |
| 2022-07-13 | Quart Barry D Chief Executive Officer | Option exercise · Restricted Stock Units | −3,646 | 32,812 | ||
| 2022-07-13 | Quart Barry D Chief Executive Officer | Option exercise · Restricted Stock Units | −16,122 | 147,051 | ||
| 2022-07-13 | POYHONEN JOHN President & CCO | Option exercise | +1,250 | 32,690 | ||
| 2022-07-13 | POYHONEN JOHN President & CCO | Option exercise | +4,564 | 37,254 | ||
| 2022-07-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −2,012 | $3.01 | $6K | 35,242 |
| 2022-07-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 11,250 | ||
| 2022-07-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −4,564 | 41,628 | ||
| 2022-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 17,892 | ||
| 2022-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,933 | 19,825 | ||
| 2022-07-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $3.01 | $3K | 18,965 |
| 2022-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 4,969 | ||
| 2022-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −1,933 | 17,626 | ||
| 2022-07-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 12,122 |
Page 20 of 28 · 557 trades